Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioNTech SE BNTX

Healthcare Biotechnology
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a... see more

Recent & Breaking News (NDAQ:BNTX)

BioNTech Shareholder Notice

Newsfile March 6, 2024

BNTX DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

Newsfile March 6, 2024

Class Action Filed Against BioNTech SE (BNTX) - March 12, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire March 6, 2024

BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Newsfile March 6, 2024

BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire March 6, 2024

BioNTech SE Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX

Accesswire March 6, 2024

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Accesswire March 6, 2024

BioNTech SE Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline on March 12, 2024 in Securities Fraud Class Action Lawsuit

Accesswire March 6, 2024

TUESDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Newsfile March 6, 2024

BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024

GlobeNewswire March 6, 2024

Levi & Korsinsky Notifies Shareholders of BioNTech SE(BNTX) of a Class Action Lawsuit and an Upcoming Deadline

PR Newswire March 6, 2024

BioNTech SE Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BNTX

Accesswire March 6, 2024

IMMINENT BNTX DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioNTech SE Investors to Join the Class Action Lawsuit!

Accesswire March 6, 2024

BioNTech SE Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - BNTX

Accesswire March 5, 2024

Final Deadline Approaching for BNTX Investors: Kessler Topaz Meltzer & Check, LLP Reminds BioNTech SE (BNTX) Investors of Class Action Lawsuit Deadline on March 12, 2024

Newsfile March 5, 2024

BioNTech SE Class Action: Levi & Korsinsky Reminds BioNTech Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTX

Accesswire March 5, 2024

BNTX IMPORTANT DEADLINE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action - BNTX

PR Newswire March 5, 2024

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioNTech SE (BNTX) Shareholders

Accesswire March 5, 2024

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in BioNTech SE with Losses of $100,000 to Contact the Firm

Accesswire March 5, 2024

Shareholders That Lost Money on BioNTech SE(BNTX) Should Contact Levi & Korsinsky About Pending Class Action - BNTX

Accesswire March 5, 2024